127 related articles for article (PubMed ID: 1631501)
21. Serum testosterone as a prognostic factor in patients with advanced prostatic carcinoma.
Iversen P; Rasmussen F; Christensen IJ
Scand J Urol Nephrol Suppl; 1994; 157():41-7. PubMed ID: 7939452
[TBL] [Abstract][Full Text] [Related]
22. Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
Hsing AW; Comstock GW
Cancer Epidemiol Biomarkers Prev; 1993; 2(1):27-32. PubMed ID: 8420607
[TBL] [Abstract][Full Text] [Related]
23. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in the saliva.
Boccon-Gibod L; Laudat MH; Guiban D; Steg A
Prog Clin Biol Res; 1987; 243A():45-53. PubMed ID: 3659006
[TBL] [Abstract][Full Text] [Related]
24. The effects of orchidectomy, estrogens, and cyproterone acetate on plasma testosterone, LH, and FSH concentrations in patients with carcinoma of the prostate.
Varenhorst E; Wallentin L; Carlström K
Scand J Urol Nephrol; 1982; 16(1):31-6. PubMed ID: 6211762
[TBL] [Abstract][Full Text] [Related]
25. [Serum dihydrotestosterone versus total testosterone values of patients with laryngeal carcinomas and chronic laryngitis].
Kleemann D; Kunkel S
Laryngorhinootologie; 1996 Jun; 75(6):351-5. PubMed ID: 8766382
[TBL] [Abstract][Full Text] [Related]
26. [Subcapsular orchiectomy using the ultrasonic surgical aspirator in patients with advanced prostatic cancer].
Yasumoto R; Minami H; Yoshihara H; Maekawa T; Ameno Y; Hayashi S; Nishisaka N; Kishimoto T
Hinyokika Kiyo; 1992 Dec; 38(12):1379-81. PubMed ID: 1288226
[TBL] [Abstract][Full Text] [Related]
27. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
28. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
Tomić R
Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
[TBL] [Abstract][Full Text] [Related]
29. Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
Ahmann FR; Crawford ED; Kreis W; Levasseur Y
Cancer Res; 1987 Sep; 47(17):4736-9. PubMed ID: 3621171
[TBL] [Abstract][Full Text] [Related]
30. Pretreatment hormone levels in prostatic cancer.
Haapiainen R; Rannikko S; Alfthan O; Adlercreutz H
Scand J Urol Nephrol Suppl; 1988; 110():137-43. PubMed ID: 3187401
[TBL] [Abstract][Full Text] [Related]
31. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
[TBL] [Abstract][Full Text] [Related]
32. Comparison of subcapsular and total orchiectomy for treatment of metastatic prostate cancer.
Zhang XZ; Donovan MP; Williams BT; Mohler JL
Urology; 1996 Mar; 47(3):402-4. PubMed ID: 8633409
[TBL] [Abstract][Full Text] [Related]
33. Intraprostatic testosterone and dihydrotestosterone. Part II: concentrations after androgen hormonal manipulation in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Meuleman EJ; van Moorselaar RJ; Bui HN; Blankenstein MA; Heijboer AC; Vis AN
BJU Int; 2012 Jan; 109(2):183-8. PubMed ID: 21992404
[TBL] [Abstract][Full Text] [Related]
34. [Testosterone serum concentrations after subcapsular orchiectomy (author's transl)].
Senge T; Hülshoff T; Tunn U; Schenck B; Neumann F
Urologe A; 1978 Nov; 17(6):382-4. PubMed ID: 726161
[TBL] [Abstract][Full Text] [Related]
35. Androgen and prostatic stroma.
Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
[TBL] [Abstract][Full Text] [Related]
36. Familial prostatic cancer risk and low testosterone.
Meikle AW; Stanish WM
J Clin Endocrinol Metab; 1982 Jun; 54(6):1104-8. PubMed ID: 7200486
[TBL] [Abstract][Full Text] [Related]
37. Serum testosterone and dihydrotestosterone in carcinoma of the prostate.
Ghanadian R; Puah CM; O'Donoghue EP
Br J Cancer; 1979 Jun; 39(6):696-9. PubMed ID: 444409
[TBL] [Abstract][Full Text] [Related]
38. Ultrafiltrable plasma testosterone and 5 alpha-dihydrotestosterone as measured across the human testes.
Tamm J; Volkwein U; Becker H
J Steroid Biochem; 1984 Oct; 21(4):471-3. PubMed ID: 6492805
[TBL] [Abstract][Full Text] [Related]
39. Assessment of the critical level of androgen for growth response of transplantable human prostatic carcinoma (PC-82) in nude mice.
van Weerden WM; van Steenbrugge GJ; van Kreuningen A; Moerings EP; de Jong FH; Schröder FH
J Urol; 1991 Mar; 145(3):631-4. PubMed ID: 1997720
[TBL] [Abstract][Full Text] [Related]
40. Possible bone-preserving capacity of high-dose intramuscular depot estrogen as compared to orchidectomy in the treatment of patients with prostatic carcinoma.
Carlström K; Stege R; Henriksson P; Grande M; Gunnarsson PO; Pousette A
Prostate; 1997 May; 31(3):193-7. PubMed ID: 9167772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
